Ad
related to: drugs that cause hypoglycemia list of names and treatment
Search results
Results from the WOW.Com Content Network
Some causes of hypoglycemia require treatment of the underlying cause to best prevent hypoglycemia. [2] This is the case for insulinomas which often require surgical removal of the tumor for hypoglycemia to remit. [2] In patients who cannot undergo surgery for removal of the insulinoma, diazoxide or octreotide may be used. [2]
Drugs used in diabetes treat types of diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin, most GLP-1 receptor agonists (liraglutide, exenatide, and others), and pramlintide, all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic agents ...
Insulin glargine/lixisenatide, marketed under the brand name Soliqua, [145] is a fixed-dose combination medication that combines insulin glargine and lixisenatide for the treatment of diabetes. [146] The most common side effects include (hypoglycemia, diarrhea, vomiting, and nausea .
Most tumors causing hypoglycemia by mechanisms other than insulin excess occur in adults. [citation needed] Insulin-induced hypoglycemia Insulin injected for diabetes; Factitious insulin injection (Munchausen syndrome) Excessive effects of oral Anti-diabetic medication, beta-blockers, or drug interactions
In diabetics, hypoglycemia can occur as a result of too much insulin or antidiabetic medication, insufficient food intake, or sudden increase in physical activity or exercise. The most common glucose-elevating agents used to treat diabetic hypoglycemia are glucose (in the form of tablets or liquid) and glucagon injections when severe ...
As a result, different GLP-1 agonist drugs are modified in various ways to extend the half-life, resulting in drugs that can be dosed multiple times per day, daily, weekly, or less often. [29] Most synthetic GLP-1 agonists are delivered via subcutaneous injection , which is a barrier to their use and reason for discontinuation. [ 37 ]
Hypoglycemia can also be caused by sulfonylureas in people with type 2 diabetes, although it is far less common because glucose counterregulation generally remains intact in people with type 2 diabetes. Severe hypoglycemia rarely, if ever, occurs in people with diabetes treated only with diet, exercise, or insulin sensitizers.
Bexagliflozin was approved in the United States under the brand name Brenzavvy in January 2023. [25] Canagliflozin is the first SGLT2 inhibitor to be approved for use in the United States. It was approved in March 2013, under the brand name Invokana and it was also marketed throughout the European Union under the same name. [26] [27]
Ad
related to: drugs that cause hypoglycemia list of names and treatment